Copyright 2013 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
To the Editor The finding of an inverse relationship between melatonin level and risk for developing type 2 diabetes in the Nurses’ Health Study (NHS) cohort1 potentially provides additional evidence for the emerging recognition that disruption of circadian timing increases the risk for metabolic and cardiovascular disease.2
Abbott SM, Zee PC. Melatonin Level and Risk for Type 2 Diabetes. JAMA. 2013;310(5):536–537. doi:10.1001/jama.2013.7649
Customize your JAMA Network experience by selecting one or more topics from the list below.